NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

Neuren to commence new on-market share buy-back program

Date and time
Announcement type
Buybacks & Capital Management

More from Health Care

More News

ARLCompany Update12 November 2026

Ardea Resources (ASX: ARL) Scandium Study Models US$510m NPV